Tafluprost
Glaucoma · Rx
RxGlaucomaGlaucoma PgaPreservative-free option Turquoise cap
| Strength | 0.0015% |
|---|---|
| Typical quantity | 0.3 mL PF vials, 30/box (brand, limited generic) |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Prostaglandin analog (FP agonist) |
| Mechanism of action | Fluorinated FP-receptor agonist; uveoscleral outflow enhancement. The first preservative-free PGA in the US. |
| Indication / reason for use | Open-angle glaucoma and ocular hypertension, particularly with ocular surface disease or BAK intolerance. |
| Usual adult dosing | 1 drop once daily in the evening (single-use vials). |
| Preservative | Preservative-free , a preservative-free option exists |
| Contact lenses | Preservative-free, lower surface burden; still generally instilled with lenses out per label. |
| Common / important adverse effects | Hyperemia, lash and pigment changes, periorbitopathy; less surface toxicity than preserved PGAs. |
| Contraindications & cautions | As for the PGA class. |
| Pregnancy / lactation | Avoid where possible. |
| Pregnancy category (older labels) | Category C on the label (the FDA retired letter categories in 2015). From DailyMed labels, checked Nov 2026. |
| Trade names | Zioptan |
| Practice notes | Preferred PGA for dry eye / BAK-sensitive patients and those on multiple drops. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.